Resumo

ARREDONDO BRUCE, Alfredo Enrique; ACUNA SOBRINO, Jorge Alfredo  e  ARREDONDO RUBIDO, Alfredo Enrique. Aspirin dosage in the acute coronary syndrome. Rev.Med.Electrón. [online]. 2015, vol.37, n.4, pp. 364-373. ISSN 1684-1824.

Background: Few clinical trials have been published proving the cardiovascular disease secondary prevention. We presented a review of the recently published literature on the aspirin dosage in patients with acute coronary syndrome. Outcomes: Well documented clinical trials assessing the comparative efficacy of different aspirin doses are very scarce in the international literature. Discussion: this complex anti-platelet therapy makes very difficult identifying the exact aspirin doses for achieving the best results with efficacy and minimizing the risk of adverse events, answering to several norms and recommendations. Conclussions: In spite of this fact, current evidence suggests that the aspirin doses of 75-100 mg/day offers an optimal benefit/risk proportion in patients with acute coronary syndrome.

Palavras-chave : aspirin doses; prevention; cardiovascular disease.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )